201 related articles for article (PubMed ID: 19562778)
21. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
22. Association study of DKK2 polymorphisms with alcohol dependence and alcohol-related harm.
Kim JY; Bae JS; Park BL; Kim JH; Kim LH; Kim JW; Lee BC; Kang TC; Choi IG; Shin HD
Alcohol Clin Exp Res; 2014 Feb; 38(2):545-50. PubMed ID: 24117450
[TBL] [Abstract][Full Text] [Related]
23. Genotype and haplotype analysis of WNT genes in non-syndromic cleft lip with or without cleft palate.
Mostowska A; Hozyasz KK; Biedziak B; Wojcicki P; Lianeri M; Jagodzinski PP
Eur J Oral Sci; 2012 Feb; 120(1):1-8. PubMed ID: 22288914
[TBL] [Abstract][Full Text] [Related]
24. High-resolution Melting PCR Analysis for Genotyping Lys109Arg and Gln223Arg in Patients with Renal Cell Carcinoma.
Zhang HP; Zou J; Yin Y; Ruan J; Xu ZQ; Yang SD; Mu HJ
Ann Clin Lab Sci; 2016 Jul; 46(4):367-73. PubMed ID: 27466295
[TBL] [Abstract][Full Text] [Related]
25. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina.
Nakamura RE; Hunter DD; Yi H; Brunken WJ; Hackam AS
BMC Cell Biol; 2007 Dec; 8():52. PubMed ID: 18093317
[TBL] [Abstract][Full Text] [Related]
26. WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates.
Katoh M; Katoh M
Int J Mol Med; 2007 Jan; 19(1):197-201. PubMed ID: 17143565
[TBL] [Abstract][Full Text] [Related]
27. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
Zhong W; Wang X; Pan B; Su Z
Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
[TBL] [Abstract][Full Text] [Related]
29. DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.
Hirata H; Hinoda Y; Majid S; Chen Y; Zaman MS; Ueno K; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R
Cancer; 2011 Apr; 117(8):1649-60. PubMed ID: 21472712
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
31. MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.
Revet I; Huizenga G; Koster J; Volckmann R; van Sluis P; Versteeg R; Geerts D
Cancer Lett; 2010 Mar; 289(2):195-207. PubMed ID: 19815336
[TBL] [Abstract][Full Text] [Related]
32. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
33. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
[TBL] [Abstract][Full Text] [Related]
34. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
35. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
36. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
37. Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.
You A; Fokas E; Wang LF; He H; Kleb B; Niederacher D; Engenhart-Cabillic R; An HX
J Cancer Res Clin Oncol; 2011 Apr; 137(4):621-7. PubMed ID: 20532910
[TBL] [Abstract][Full Text] [Related]
38. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
40. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
